Orchestra BioMed CFO shares withheld for RSU taxes

Orchestra BioMed Holdings, Inc. Chief Financial Officer Andrew Taylor Lawrence reported a tax-related share withholding linked to restricted stock unit vesting.

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. Chief Financial Officer Andrew Taylor Lawrence reported a tax-related share withholding linked to restricted stock unit vesting. The issuer withheld 36,352 shares of common stock at an implied value of $4.02 per share to satisfy tax withholding obligations, and no shares were sold in the market. After this withholding, Lawrence directly holds 593,065 shares of Orchestra BioMed common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 36,352 shares

Exercise Price or Tax Liability 1 txn

Insider Taylor Andrew Lawrence

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.0001 per share	36,352	$4.02	$146K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 593,065 shares (Direct)

Footnotes (1)

1. F1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Key Figures

Shares withheld for taxes: 36,352 shares Implied share value: $4.02 per share Shares held after transaction: 593,065 shares

3 metrics

Shares withheld for taxes 36,352 shares Withholding to satisfy RSU tax obligations

Implied share value $4.02 per share Value used for tax-withholding disposition

Shares held after transaction 593,065 shares Direct holdings of CFO after withholding

Key Terms

restricted stock units ("RSUs"), tax withholding obligations, withholding of shares, tax-withholding disposition

4 terms

restricted stock units ("RSUs") financial

"in connection with vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with vesting of restricted stock units"

withholding of shares financial

"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations"

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Orchestra BioMed (OBIO) disclose in this Form 4 for its CFO?

Orchestra BioMed reported that CFO Andrew Taylor Lawrence had shares withheld to cover taxes on vested RSUs. The issuer withheld 36,352 common shares, and no shares were sold in the market as part of this transaction.

Did the Orchestra BioMed (OBIO) CFO sell shares in the open market?

No, the CFO did not sell shares in the open market. The filing states the issuer withheld 36,352 shares solely to satisfy tax withholding obligations related to restricted stock unit vesting.

How many Orchestra BioMed (OBIO) shares were withheld for the CFO’s taxes?

The company withheld 36,352 shares of common stock for tax obligations tied to RSU vesting. The transaction is coded as a tax-withholding disposition rather than an open-market sale or purchase.

How many Orchestra BioMed (OBIO) shares does the CFO hold after this transaction?

Following the tax-withholding transaction, CFO Andrew Taylor Lawrence directly holds 593,065 shares of Orchestra BioMed common stock. This figure reflects his position after the 36,352 shares were withheld to meet RSU-related tax obligations.

What does the F code mean in the Orchestra BioMed (OBIO) Form 4?

The F transaction code indicates a disposition of shares to satisfy tax obligations or exercise price. Here, it reflects 36,352 shares withheld by the issuer for RSU-related tax withholding, not an open-market sale by the CFO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Andrew Lawrence

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PENNSYLVANIA 18938

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	06/10/2026		F(1)		36,352	D	$4.02	593,065	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

	/s/ Andrew Taylor	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)